HomeCYAD • EBR
add
Celyad Oncology SA
Previous close
€0.32
Day range
€0.32 - €0.32
Year range
€0.16 - €0.65
Market cap
14.04M EUR
Avg Volume
17.68K
P/E ratio
16.24
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.50K | -95.93% |
Operating expense | -1.06M | -171.83% |
Net income | 2.25M | 262.05% |
Net profit margin | 64.36K | 4,081.81% |
Earnings per share | — | — |
EBITDA | 1.07M | 179.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.71M | -59.33% |
Total assets | 4.30M | -56.71% |
Total liabilities | 1.86M | -80.23% |
Total equity | 2.44M | — |
Shares outstanding | 44.76M | — |
Price to book | 6.34 | — |
Return on assets | 61.92% | — |
Return on capital | 109.25% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.25M | 262.05% |
Cash from operations | -1.81M | -27.27% |
Cash from investing | 1.50M | 19,946.67% |
Cash from financing | 765.00K | 89.36% |
Net change in cash | 459.00K | 145.24% |
Free cash flow | 670.31K | 188.59% |
About
Founded
2004
Headquarters
Website
Employees
5
